CLINICAL_TRIALS
trial_result
· 2021-02-16
Clinical Trial Update: A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults [Phase 2]
Summary
Phase 2 proof-of-concept study of GSK3640254 in treatment-naive adults with HIV-1 completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2021-02-16